ArticleBreast cancer research and treatment2026

Molecular imaging of tucatinib-induced cellular and TME changes in preclinical models of HER2 + breast cancer.

Patrick N Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.